We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $8.43B
1-Year Est. Return 52.02%
This Fund
S&P 500
This Quarter Est. Return
+25.07%
1 Year Est. Return
+52.02%
3 Year Est. Return
+115.13%
5 Year Est. Return
+140.59%
10 Year Est. Return
+558.15%
AUM
$8.43B
AUM Growth
+$1.45B
Cap. Flow
+$163M
Cap. Flow %
1.93%
Top 10 Hldgs %
12.93%
Holding
678
New
102
Increased
209
Reduced
234
Closed
88

Top Buys

Rank Stock Value
1
TKR icon
Timken Company
TKR
+$45.3M
2
MARA icon
Marathon Digital Holdings
MARA
+$34.5M
3
LLY icon
Eli Lilly
LLY
+$29M
4
AVT icon
Avnet
AVT
+$26.8M
5
IEX icon
IDEX
IEX
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Industrials 21.43%
3 Financials 13.12%
4 Healthcare 12.2%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UCB
101
United Community Banks
UCB
$4.3B
$25M 0.3%
712,727
+30,726
+5% +$1.03M
AAP icon
102
Advance Auto Parts
AAP
$2.67B
$25M 0.3%
401,773
+4,443
+1% +$252K
HALO icon
103
Halozyme
HALO
$12.5B
$24.9M 0.3%
317,924
+19,868
+7% +$1.35M
SYK icon
104
Stryker
SYK
$116B
$24.8M 0.29%
78,776
+9,044
+13% +$2.85M
MUR icon
105
Murphy Oil
MUR
$5.22B
$24.6M 0.29%
756,510
-130,474
-15% -$4.99M
PDFS icon
106
PDF Solutions
PDFS
$1.93B
$24.6M 0.29%
+347,244
New +$17.2M
NX icon
107
Quanex
NX
$1.05B
$24.6M 0.29%
1,320,139
+92,654
+8% +$1.71M
SU icon
108
Suncor Energy
SU
$78.8B
$24.3M 0.29%
452,659
+7,410
+2% +$469K
KRYS icon
109
Krystal Biotech
KRYS
$10.6B
$24.2M 0.29%
65,211
-14,286
-18% -$4.27M
ADI icon
110
Analog Devices
ADI
$176B
$24.2M 0.29%
60,849
+38,504
+172% +$15.2M
SLGN icon
111
Silgan Holdings
SLGN
$4.35B
$24.1M 0.29%
520,416
-174,228
-25% -$6.96M
AEIS icon
112
Advanced Energy
AEIS
$11.3B
$23.9M 0.28%
64,077
-13,462
-17% -$4.71M
GMED icon
113
Globus Medical
GMED
$10.5B
$23.7M 0.28%
300,334
+46,449
+18% +$3.95M
QDEL icon
114
QuidelOrtho
QDEL
$958M
$23.6M 0.28%
1,345,530
-197,880
-13% -$2.61M
GKOS icon
115
Glaukos
GKOS
$10.5B
$23.5M 0.28%
168,445
+43,494
+35% +$5.5M
NDSN icon
116
Nordson
NDSN
$17.7B
$23.5M 0.28%
77,984
+17,082
+28% +$4.85M
CECO icon
117
Ceco Environmental
CECO
$4.34B
$23.5M 0.28%
259,165
+84,111
+48% +$6.65M
BNY
118
Bank of New York Mellon
BNY
$112B
$23.4M 0.28%
161,959
-6,342
-4% -$867K
RGEN icon
119
Repligen
RGEN
$9.46B
$23.2M 0.27%
169,811
+14,786
+10% +$1.82M
ALGM icon
120
Allegro MicroSystems
ALGM
$6.82B
$23.1M 0.27%
332,440
-712,544
-68% -$33.3M
ECL icon
121
Ecolab
ECL
$78.3B
$22.9M 0.27%
82,137
+8,052
+11% +$2.12M
CVCO icon
122
Cavco Industries
CVCO
$4.35B
$22.9M 0.27%
37,226
+653
+2% +$347K
VTV icon
123
Vanguard Morningstar Value ETF
VTV
$193B
$22.8M 0.27%
104,817
-41,708
-28% -$8.71M
COLB icon
124
Columbia Banking Systems
COLB
$8.71B
$22.8M 0.27%
712,060
-119,956
-14% -$3.56M
KRC icon
125
Kilroy Realty
KRC
$4.32B
$22.7M 0.27%
605,262
-16,555
-3% -$563K

Similar funds

Segall Bryant & Hamill's Q2 2026 Portfolio in Review

As of Q2 2026, Segall Bryant & Hamill held 678 positions worth $8.43B, up 21% from $6.98B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Segall Bryant & Hamill's Q2 2026 filing shows 102 new, 209 increased, 234 reduced and 88 closed positions. Its largest new stake was Marathon Digital Holdings: 2,756,177 shares worth $38.3M. The largest sale was Onto Innovation, an estimated $45.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2026 buy was Marathon Digital Holdings: 2,756,177 shares worth $38.3M.
  • Segall Bryant & Hamill added most to Timken Company in Q2 2026, an estimated $45.3M increase.
  • Segall Bryant & Hamill's biggest Q2 2026 reduction was Onto Innovation, cutting an estimated $45.9M.
  • Segall Bryant & Hamill fully exited Axcelis in Q2 2026, selling an estimated $18.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 13% of its $8.43B portfolio in Q2 2026.
  • Segall Bryant & Hamill opened 102 new positions and closed 88 in Q2 2026.
  • Segall Bryant & Hamill's portfolio value rose 21% quarter-over-quarter to $8.43B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.